Hepatology InternationalSCIE

文章摘录

• Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study Author: Yang, Shi-Ye; Feng, Jin-Kai; Yan, Mao-Lin; Guo, Lei; Duan, Yun-Fei; Ye, Jia-Zhou; Liu, Zong-Han; Xiang, Yan-Jun; Xu, Li; Xue, Jie; Shi, Jie; Lau, Wan Yee; Cheng, Shu-Qun; Guo, Wei-Xing Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s12072-023-10492-2
• Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial Author: Yang, Fan; Zheng, Xiaofang; Koh, Sarene; Lu, Jianxi; Cheng, Jintao; Li, Panlong; Du, Cong; Chen, Yunhao; Chen, Xiaoyan; Yang, Li; Chen, Wanxin; Wong, Regina Wanju; Wai, Lu-En; Wang, Tingting; Zhang, Qi; Chen, Wenjie Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s12072-023-10524-x
• OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma Author: Tan, Juntao; Yu, Yue; Lin, Xiantian; He, Yuxin; Jin, Wen; Qian, Hong; Li, Ying; Xu, Xiaomei; Zhao, Yuxi; Ning, Jianwen; Zhang, Zhengyu; Chen, Jingjing; Wu, Xiaoxin Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s12072-023-10516-x
• miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression Author: Qiu, Jiannan; Wu, Shasha; Wang, Peng; Zhou, Yan; Wang, Zhongxia; Sun, Yong; Jiang, Chunping Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. 17, Issue 2, pp. 463-475. DOI: 10.1007/s12072-022-10404-w
• The association between visceral adipocyte hypertrophy and NAFLD in subjects with different degrees of adiposity Author: Sun, Haixiang; Fang, Da; Wang, Hongdong; Wang, Jin; Yuan, Yue; Huang, Shanshan; Ma, Huayang; Gu, Tianwei; Bi, Yan Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. 17, Issue 1, pp. 215-224. DOI: 10.1007/s12072-022-10409-5
• Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection Author: Li, Minghui; Sun, Fangfang; Bi, Xiaoyue; Lin, Yanjie; Yang, Liu; Jiang, Tingting; Deng, Wen; Lu, Yao; Zhang, Lu; Yi, Wei; Xie, Yao Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. 17, Issue 1, pp. 42-51. DOI: 10.1007/s12072-022-10412-w
• N-terminal propeptide of type 3 collagen-based sequential algorithm can identify high-risk steatohepatitis and fibrosis in MAFLD Author: Tang, Liang-Jie; Li, Gang; Eslam, Mohammed; Zhu, Pei-Wu; Chen, Sui-Dan; Leung, Howard Ho-Wai; Huang, Ou-Yang; Wong, Grace Lai-Hung; Zhou, Yu-Jie; Karsdal, Morten; Leeming, Diana Julie; Jiang, Pei; Wang, Cong; Yuan, Hai-Yang; Byrne, Christopher D.; Targher, Giovanni; George, Jacob; Wong, Vincent Wai-Sun; Zheng, Ming-Hua Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. 17, Issue 1, pp. 190-201. DOI: 10.1007/s12072-022-10420-w
• Metabolic dysfunction-associated fatty liver disease and liver function markers are associated with Crohn's disease but not Ulcerative Colitis: a prospective cohort study Author: Chen, Jie; Dan, Lintao; Tu, Xinru; Sun, Yuhao; Deng, Minzi; Chen, Xuejie; Hesketh, Therese; Li, Ran; Wang, Xiaoyan; Li, Xue Journal: HEPATOLOGY INTERNATIONAL. 2023; Vol. 17, Issue 1, pp. 202-214. DOI: 10.1007/s12072-022-10424-6